Ethereum sets 2029 target for quantum resistance
Ethereum (CRYPTO:ETH) has set December 2029 as its target for quantum resistance.

Founder and CEO of Grafa, leading the company's vision to democratise financial data and empower investors with innovative tools.
Ethereum (CRYPTO:ETH) has set December 2029 as its target for quantum resistance.
The S&P/ASX 200 is set to open 0.7% lower on Sept. 21 as investors price in three potential interest rate increases by the Reserve Bank of Australia.
Ramelius Resources (ASX:RMS) updated its medium-term production outlook, forecasting annual gold output to reach between 560 and 610 kilo-ounces by FY30.
EU banks have doubled their presence on the MiCA register to about 80 institutions since June 26.
UAE and Swedish authorities have arrested seven suspects after tracing an alleged crypto-linked laundering network handling about $7.1 million.
XORTX Therapeutics (NASDAQ:XRTX) announced plans to submit an Investigational New Drug (IND) application to the U.S. Food and Drug Administration in the fourth quarter of 2026 for its XRx-026 gout program using the XORLO formulation of oxypurinol.
Chanson International Holding (NASDAQ:CHSN) reported net income of $0.8 million for the six months ended June 30, 2026, compared with a net loss of $1 million in the same period a year earlier.
The Cato Corporation (NYSE:CATO) plans to close approximately 70 additional underperforming stores during the third and fourth quarters of fiscal 2026, bringing total planned store closures for the year to about 120 locations.
Natera (NASDAQ:NTRA) presented new data from its Signatera molecular residual disease (MRD) test at the IASLC 2026 World Conference on Lung Cancer, including results from a 1,129-patient analysis in early-stage non-small cell lung cancer.
Binance’s withdrawn Greek MiCA application has come under renewed scrutiny following reports about European officials’ involvement in the process.
Got a second for a cookie? 🍪Essential cookies keep Grafa running smoothly. A few optional ones help us see what's working so we can make it better. You're in control — change your mind any time. Cookie policy · Privacy policy